Cargando…
Nine per cent of biopsy‐proven lentigo maligna lesions are reclassified as lentigo maligna melanoma after surgery
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850063/ https://www.ncbi.nlm.nih.gov/pubmed/30716164 http://dx.doi.org/10.1111/bjd.17714 |
| _version_ | 1783469336310054912 |
|---|---|
| author | Zoutendijk, J. Tio, D. Koljenovic, S. van den Bos, R.R. |
| author_facet | Zoutendijk, J. Tio, D. Koljenovic, S. van den Bos, R.R. |
| author_sort | Zoutendijk, J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6850063 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-68500632019-11-15 Nine per cent of biopsy‐proven lentigo maligna lesions are reclassified as lentigo maligna melanoma after surgery Zoutendijk, J. Tio, D. Koljenovic, S. van den Bos, R.R. Br J Dermatol Correspondence John Wiley and Sons Inc. 2019-04-15 2019-08 /pmc/articles/PMC6850063/ /pubmed/30716164 http://dx.doi.org/10.1111/bjd.17714 Text en © 2019 The Authors. British Journal of Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Correspondence Zoutendijk, J. Tio, D. Koljenovic, S. van den Bos, R.R. Nine per cent of biopsy‐proven lentigo maligna lesions are reclassified as lentigo maligna melanoma after surgery |
| title | Nine per cent of biopsy‐proven lentigo maligna lesions are reclassified as lentigo maligna melanoma after surgery |
| title_full | Nine per cent of biopsy‐proven lentigo maligna lesions are reclassified as lentigo maligna melanoma after surgery |
| title_fullStr | Nine per cent of biopsy‐proven lentigo maligna lesions are reclassified as lentigo maligna melanoma after surgery |
| title_full_unstemmed | Nine per cent of biopsy‐proven lentigo maligna lesions are reclassified as lentigo maligna melanoma after surgery |
| title_short | Nine per cent of biopsy‐proven lentigo maligna lesions are reclassified as lentigo maligna melanoma after surgery |
| title_sort | nine per cent of biopsy‐proven lentigo maligna lesions are reclassified as lentigo maligna melanoma after surgery |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850063/ https://www.ncbi.nlm.nih.gov/pubmed/30716164 http://dx.doi.org/10.1111/bjd.17714 |
| work_keys_str_mv | AT zoutendijkj ninepercentofbiopsyprovenlentigomalignalesionsarereclassifiedaslentigomalignamelanomaaftersurgery AT tiod ninepercentofbiopsyprovenlentigomalignalesionsarereclassifiedaslentigomalignamelanomaaftersurgery AT koljenovics ninepercentofbiopsyprovenlentigomalignalesionsarereclassifiedaslentigomalignamelanomaaftersurgery AT vandenbosrr ninepercentofbiopsyprovenlentigomalignalesionsarereclassifiedaslentigomalignamelanomaaftersurgery |